opn1sw1 Antibody

What is OPN1SW and why is it important in vision research?

OPN1SW, also known as short-wave-sensitive opsin 1, is a protein that functions as a blue cone photoreceptor pigment in the retina. It belongs to the G-protein coupled receptor 1 family within the opsin subfamily and plays a critical role in color vision, specifically in the detection of short-wavelength (blue) light. The protein has a reported length of 348 amino acid residues and a molecular mass of approximately 39.1 kDa in humans . OPN1SW is primarily expressed in the retina, with some expression also detected in the testis .

The importance of OPN1SW in vision research stems from its fundamental role in color perception. Mutations in the OPN1SW gene are associated with tritan color blindness, a rare form of color vision deficiency that affects the perception of blue and yellow colors . By studying OPN1SW, researchers gain insights into the molecular mechanisms of color vision, photoreceptor development, and potential therapeutic approaches for vision disorders.

What applications are OPN1SW antibodies most commonly used for?

OPN1SW antibodies are utilized across multiple experimental techniques in vision research. The most widely reported applications include:

• Western Blot (WB): For detecting and quantifying OPN1SW protein expression in tissue lysates

• Enzyme-Linked Immunosorbent Assay (ELISA): For sensitive detection of OPN1SW protein levels

• Immunohistochemistry (IHC): For visualizing OPN1SW distribution in tissue sections

• Immunofluorescence (IF): Particularly useful for co-localization studies in retinal tissue

• Immunocytochemistry (ICC): For examining OPN1SW expression in cultured cells

Among these applications, Western Blot appears to be the most commonly used technique, as it allows researchers to verify the specificity of the antibody while providing information about protein expression levels . Immunofluorescence on paraffin-embedded tissues (IF-P) is another valuable application, particularly for studying OPN1SW distribution in retinal tissues .

What species reactivity should be considered when selecting an OPN1SW antibody?

When selecting an OPN1SW antibody, researchers should carefully consider the species reactivity based on their experimental model. From the available data, OPN1SW antibodies with reactivity to human and mouse samples are commonly available . Additionally, some antibodies show cross-reactivity with samples from multiple species including rabbit, rat, dog, guinea pig, and horse .

OPN1SW gene orthologs have been identified in various vertebrate species including mouse, rat, bovine, frog, zebrafish, and chimpanzee . This conservation suggests potential cross-reactivity of certain antibodies across these species, though validation is always necessary.

The selection of an appropriate antibody should align with the experimental model organism. For researchers working with human samples or model organisms like mice, there appears to be a broader selection of validated antibodies available .

What criteria should be considered when selecting an OPN1SW antibody for research?

Selecting the appropriate OPN1SW antibody requires careful consideration of several key criteria:

• Application compatibility: Verify that the antibody has been validated for your specific application (WB, IF, IHC, ELISA)

• Species reactivity: Ensure the antibody recognizes OPN1SW in your species of interest

• Antibody type:

  • Polyclonal antibodies (like 24660-1-AP) offer high sensitivity and recognize multiple epitopes

  • Monoclonal antibodies provide higher specificity but may be less sensitive for certain applications

• Immunogen information: Check whether the antibody was raised against the full protein or a specific region (e.g., C-terminal region)

• Validation data: Look for antibodies with substantial validation evidence, including positive controls in relevant tissues like mouse eye tissue

• Storage conditions: Consider stability requirements; most OPN1SW antibodies require storage at -20°C and contain glycerol to prevent freeze-thaw damage

• Conjugation: Determine if you need an unconjugated primary antibody or one conjugated to biotin, HRP, or fluorescent tags for direct detection

• Dilution recommendations: Review recommended working dilutions for your application (e.g., 1:50-1:500 for IF-P)

Researchers should prioritize antibodies that have been cited in peer-reviewed publications when possible, as this provides evidence of successful use in academic research contexts.

How should optimal working dilutions be determined for OPN1SW antibodies?

Determining the optimal working dilution for an OPN1SW antibody requires systematic titration to balance signal strength with background. While manufacturers provide recommended dilution ranges (e.g., 1:50-1:500 for IF-P applications ), these should serve as starting points rather than definitive values.

Methodology for antibody titration:

• Prepare a dilution series spanning the recommended range (e.g., 1:50, 1:100, 1:250, 1:500)

• Run parallel experiments using identical sample preparation and detection methods

• Include both positive controls (tissues known to express OPN1SW, such as retinal tissue) and negative controls (tissues without OPN1SW expression or primary antibody omission)

• Evaluate results based on:

  • Signal-to-noise ratio

  • Specificity of staining pattern (membrane and cytoplasmic localization for OPN1SW)

  • Reproducibility across technical replicates

  • Minimal background in negative controls

• For quantitative applications, construct a standard curve to ensure linearity of detection

As noted in the product information for certain OPN1SW antibodies, "It is recommended that this reagent should be titrated in each testing system to obtain optimal results" and results may be "sample-dependent" . This emphasizes the importance of optimization for each specific experimental context.

What controls are essential when working with OPN1SW antibodies?

Implementing appropriate controls is crucial for validating results obtained with OPN1SW antibodies:

• Positive tissue controls:

  • Mouse or human retinal tissue (known to express OPN1SW)

  • Cell lines with verified OPN1SW expression (e.g., RAW264.7 cells for certain applications)

• Negative controls:

  • Primary antibody omission: Perform parallel staining without the primary OPN1SW antibody

  • Isotype control: Use a non-specific IgG from the same host species and at the same concentration

  • Tissues known not to express OPN1SW

  • Absorption controls: Pre-incubate antibody with excess immunizing peptide to verify specificity

• Expression controls:

  • Transfected cells expressing wild-type or mutant OPN1SW (as used in the study mentioned in search result )

  • For mutation studies, both wild-type and mutant constructs should be tested, as demonstrated in HEK293T cells transfected with either mutant OPN1MW C198R opsin or WT OPN1MW-HA

• Method-specific controls:

  • For Western blot: Molecular weight markers to confirm correct band size (39 kDa for OPN1SW)

  • For IF/IHC: Secondary antibody-only controls to assess non-specific binding

  • For co-localization studies: Single-staining controls to assess bleed-through

Implementing these controls helps distinguish specific from non-specific signals and validates the accuracy of experimental results when working with OPN1SW antibodies.

What are the recommended protocols for immunofluorescence with OPN1SW antibodies?

Successful immunofluorescence (IF) with OPN1SW antibodies requires careful sample preparation and staining optimization. Based on the available information, here is a methodological approach:

For paraffin-embedded tissues (IF-P):

• Sample preparation:

  • Fix tissue samples in 4% paraformaldehyde

  • Process and embed in paraffin following standard protocols

  • Section at 4-6 μm thickness

• Antigen retrieval:

  • As noted by a verified customer: "To ensure optimal results, antigen retrieval methods should be carefully optimized"

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) is often effective

  • For challenging samples, test alternative retrieval buffers (e.g., EDTA pH 8.0)

• Blocking and permeabilization:

  • Block with 5-10% normal serum (from the same species as the secondary antibody)

  • Add 0.1-0.3% Triton X-100 for permeabilization, as OPN1SW has both membrane and cytoplasmic localization

• Primary antibody incubation:

  • Use OPN1SW antibody at optimized dilution (start with 1:50-1:500 for IF-P as recommended)

  • Incubate overnight at 4°C in a humidified chamber

• Secondary antibody detection:

  • Use fluorophore-conjugated secondary antibodies appropriate for your imaging system

  • Include DAPI for nuclear counterstaining

  • Mount with anti-fade mounting medium

The protocol should be adapted for cryosections by adjusting fixation time and potentially reducing or eliminating antigen retrieval steps. As noted in the customer review, "The antibody performs well on both cryosections and paraffin-embedded tissues" , suggesting versatility across sample preparation methods.

How can Western blot protocols be optimized for OPN1SW detection?

Optimizing Western blot protocols for OPN1SW detection requires attention to several key factors:

• Sample preparation:

  • Use RIPA buffer with protease inhibitors for tissue or cell lysis

  • For retinal tissue, specialized extraction protocols may be necessary to solubilize membrane proteins effectively

  • Heat samples at 70°C (not boiling) to prevent aggregation of this membrane protein

• Gel electrophoresis:

  • Use 10-12% SDS-PAGE gels for optimal resolution around the 39 kDa range (OPN1SW's calculated molecular weight)

  • Load appropriate positive controls (retinal tissue lysates)

• Transfer conditions:

  • Semi-dry or wet transfer systems work, but wet transfer may be preferable for membrane proteins

  • Use PVDF membranes rather than nitrocellulose for better protein retention

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk or BSA in TBST

  • Incubate with OPN1SW antibody at recommended dilution (1:500-1:1000)

  • For primary antibody incubation, overnight at 4°C often yields better results than shorter incubations

• Detection:

  • HRP-conjugated secondary antibodies with enhanced chemiluminescence detection

  • For weak signals, consider signal enhancement systems or longer exposure times

• Expected results:

  • OPN1SW should appear as a band at approximately 39 kDa

  • Multiple bands may indicate glycosylation states or degradation products

When troubleshooting, consider adjusting antibody concentration, incubation time, or washing stringency to improve signal-to-noise ratio. Some OPN1SW antibodies are specifically recommended for Western blot applications , making them preferable choices for this technique.

What special considerations apply when working with retinal tissue samples?

Retinal tissue presents unique challenges for antibody-based experiments due to its complex structure and the relatively low abundance of specific opsins like OPN1SW. Researchers should consider these methodological approaches:

• Sample collection and fixation:

  • Minimize post-mortem interval to preserve antigenicity

  • Use gentle fixation protocols (4% PFA for 1-4 hours depending on sample size)

  • Consider specialized fixatives designed for retinal tissue preservation

• Cryopreservation vs. paraffin embedding:

  • Both methods work with OPN1SW antibodies, as noted in customer feedback

  • Cryosectioning often preserves antigenicity better but may compromise morphology

  • Paraffin embedding provides better morphological preservation but requires careful antigen retrieval

• Orientation and sectioning:

  • Proper orientation is critical for retinal layers identification

  • For cone photoreceptor visualization, both transverse and tangential sections provide valuable information

  • 10-12 μm thickness for cryosections and 4-6 μm for paraffin sections

• Antigen retrieval optimization:

  • Test multiple methods as noted by researchers: "to ensure optimal results, antigen retrieval methods should be carefully optimized"

  • For OPN1SW in paraffin sections, heat-induced epitope retrieval is typically necessary

• Co-localization studies:

  • Consider dual labeling with other retinal markers (rod-specific, other cone opsins, or structural markers)

  • Use confocal microscopy to clearly distinguish cone subtypes

• Regional variations:

  • Remember that S-cones (expressing OPN1SW) have specific distribution patterns in the retina

  • Include multiple regions in analysis to account for natural variability in expression

These specialized approaches help ensure successful detection of OPN1SW in its native retinal context, particularly important for studies of color vision and retinal disorders.

How can non-specific binding be minimized when using OPN1SW antibodies?

Non-specific binding is a common challenge when working with antibodies, including those targeting OPN1SW. Several methodological approaches can minimize this issue:

• Antibody validation:

  • Select antibodies with documented specificity, such as those showing a single band at 39 kDa in Western blots

  • Antibodies purified by antigen affinity purification often show higher specificity

• Blocking optimization:

  • Test different blocking agents (BSA, normal serum, commercial blocking solutions)

  • Extend blocking time to 2 hours at room temperature

  • Add 0.1-0.3% Triton X-100 to blocking buffer to reduce hydrophobic interactions

• Antibody dilution:

  • Optimize concentration through systematic titration

  • Higher dilutions (more dilute antibody solutions) often reduce background

  • Follow recommended dilution ranges (e.g., 1:500-1:1000 for WB , 1:50-1:500 for IF-P )

• Washing protocols:

  • Increase the number and duration of washes

  • Add 0.05-0.1% Tween-20 to wash buffers

  • Consider using TBS instead of PBS for certain applications

• Sample-specific strategies:

  • For highly autofluorescent tissues like retina, include an autofluorescence quenching step

  • Pre-absorb antibodies with tissue homogenates from species of interest

  • Use specialized blocking peptides when available

• Secondary antibody considerations:

  • Pre-adsorb secondary antibodies against tissues from the target species

  • Use highly cross-adsorbed secondary antibodies

  • Match secondary antibody to the specific host species of your primary antibody

These methodological refinements should be systematically tested to determine which combination most effectively reduces non-specific binding while preserving specific OPN1SW detection.

How can OPN1SW antibodies contribute to research on color vision disorders?

OPN1SW antibodies serve as valuable tools in research on color vision disorders, particularly tritan color blindness, which is directly associated with mutations in the OPN1SW gene . These antibodies can be applied methodologically in several research contexts:

• Mutation characterization studies:

  • Detect altered protein expression or localization in samples with known OPN1SW mutations

  • As demonstrated in search result , antibodies can help verify whether antibodies recognize mutant forms of opsins: "To rule out the possibility that our antibody against L-/M-opsin is incapable of recognizing mutant OPN1MW –/– C198R, we transfected HEK293T cells with plasmids expressing either mutant OPN1MW C198Ropsin or a WT OPN1MW-HA control"

• Gene therapy evaluation:

  • Assess protein expression following gene therapy interventions

  • Recent research has shown promising results: "Gene therapy restores the structure and function of cone photoreceptors carrying the most common C203R missense mutation in cone opsin"

• Animal model validation:

  • Verify opsin expression patterns in transgenic models of color vision deficiencies

  • Compare wild-type and mutant models to understand pathological mechanisms

• Structure-function correlations:

  • Combine immunolabeling with functional assessments like electroretinography (ERG)

  • Correlate OPN1SW expression patterns with color discrimination abilities

• Drug screening applications:

  • Use antibodies to assess whether pharmacological treatments rescue protein expression or trafficking defects

  • Evaluate potential therapeutic compounds that might stabilize mutant OPN1SW

• Developmental studies:

  • Track normal and abnormal development of S-cones in relation to color vision disorders

  • Study the timing and patterning of OPN1SW expression during retinal development

These methodological approaches demonstrate how OPN1SW antibodies contribute significantly to understanding the molecular basis of color vision disorders and developing potential therapeutic strategies.

What advanced imaging techniques can be combined with OPN1SW antibodies for retinal research?

Advanced imaging techniques, when combined with OPN1SW antibodies, can provide unprecedented insights into S-cone structure, distribution, and function. Several methodological approaches are particularly valuable:

• Confocal microscopy:

  • Provides optical sectioning to precisely locate OPN1SW within cellular compartments

  • Allows for co-localization studies with multiple markers

  • Recommended settings: high numerical aperture objectives (60-100x), appropriate filter sets for fluorophores, and optimal pinhole size

• Super-resolution microscopy:

  • Techniques like STED, STORM, or PALM overcome the diffraction limit

  • Enable visualization of OPN1SW distribution within subcellular compartments

  • Critical for studying protein trafficking and membrane organization

• Two-photon microscopy:

  • Reduces phototoxicity for live imaging applications

  • Provides deeper tissue penetration for whole-mount retinal preparations

  • Particularly useful for studying intact retinal architecture

• Expansion microscopy:

  • Physical expansion of specimens allows conventional microscopes to resolve nanoscale details

  • Valuable for examining the precise arrangement of OPN1SW in photoreceptor outer segments

• Light sheet microscopy:

  • Enables rapid 3D imaging of whole retinas with reduced photobleaching

  • Useful for mapping the complete distribution of S-cones across the retina

• Correlative light and electron microscopy (CLEM):

  • Combines immunofluorescence identification of OPN1SW-positive cells with ultrastructural analysis

  • Provides insights into the morphological features of S-cones at nanometer resolution

• In vivo imaging approaches:

  • Adaptive optics scanning laser ophthalmoscopy can be combined with post-mortem antibody labeling

  • Allows correlation between in vivo function and molecular expression

When implementing these advanced techniques, researchers should optimize fixation and antibody protocols specifically for each imaging method, as certain approaches may require modifications to standard immunostaining procedures.

How are OPN1SW antibodies being used in gene therapy research?

OPN1SW antibodies play a crucial role in evaluating the efficacy of gene therapy approaches for color vision disorders. Recent methodological applications include:

• Tracking protein expression after gene delivery:

  • Antibodies verify successful expression of therapeutic genes

  • Recent research has demonstrated: "Structural and functional rescue of cones carrying the most common... missense mutation in cone opsin"

  • Antibodies help confirm that gene therapy can "restore the structure and function of cone photoreceptors"

• Assessing subcellular localization:

  • Determine whether gene therapy corrects trafficking defects common in opsin mutations

  • Compare membrane localization patterns between treated and untreated samples

• Quantitative analysis of therapeutic efficacy:

  • Measure changes in OPN1SW protein levels following intervention

  • Compare expression levels to normal controls to determine degree of restoration

• Long-term monitoring of therapeutic durability:

  • Track OPN1SW expression at various timepoints after treatment

  • Assess whether protein expression remains stable or diminishes over time

• Comparative analysis of delivery methods:

  • Evaluate different viral vectors and delivery approaches based on resulting OPN1SW expression

  • Optimize parameters for maximal therapeutic effect

• Safety assessment:

  • Monitor for aberrant OPN1SW expression patterns that might indicate off-target effects

  • Ensure appropriate cell-type specificity of therapeutic interventions

This application of OPN1SW antibodies represents a critical bridge between basic science understanding of color vision and translational research aimed at developing treatments for patients with color vision disorders.

What are the latest methodological innovations for studying OPN1SW in photoreceptor development?

Recent innovations in studying OPN1SW during photoreceptor development combine traditional antibody-based approaches with cutting-edge techniques:

• Single-cell transcriptomics coupled with protein validation:

  • Correlate OPN1SW mRNA expression profiles with protein detection

  • Map developmental trajectories of cone photoreceptor subtypes

  • Validate transcriptomic findings using OPN1SW antibodies at the protein level

• Organoid and stem cell models:

  • OPN1SW antibodies serve as crucial markers for identifying S-cones in retinal organoids

  • Monitor time course of opsin expression during differentiation protocols

  • Compare in vitro development patterns with in vivo retinal development

• CRISPR-based lineage tracing:

  • Combine genetic lineage tracing with immunohistochemical detection of OPN1SW

  • Determine the origin and developmental path of S-cones

  • Correlate genetic manipulations with protein expression consequences

• Live imaging approaches:

  • Use fluorescent reporter constructs driven by OPN1SW promoters

  • Validate reporter expression patterns with antibody staining

  • Track the dynamic development of S-cones in real-time

• Epigenetic profiling:

  • Correlate chromatin accessibility and histone modifications with OPN1SW expression

  • Use antibodies to verify protein expression resulting from epigenetic changes

  • Identify regulatory mechanisms controlling S-cone development

• Cross-species comparative approaches:

  • Apply OPN1SW antibodies across model systems to identify conserved developmental mechanisms

  • Study species-specific variations in S-cone development and patterning

These methodological innovations provide deeper insights into the molecular mechanisms governing photoreceptor specification, differentiation, and maturation, with important implications for understanding retinal development and potential regenerative approaches.

How can researchers combine functional studies with OPN1SW antibody detection?

Integrating functional assessments with OPN1SW antibody detection creates powerful experimental paradigms that link molecular presence to physiological function:

• Structure-function correlation:

  • Combine electroretinography (ERG) with subsequent immunohistochemical analysis

  • Record S-cone specific responses using specialized stimuli

  • Map functional responses to anatomical distribution of OPN1SW-positive cells

• Calcium imaging paired with immunohistochemistry:

  • Use calcium indicators to record light responses in retinal preparations

  • Apply OPN1SW antibodies post-recording to identify S-cones

  • Correlate specific response properties with OPN1SW expression

• Electrophysiology and post-hoc identification:

  • Perform patch-clamp recordings from cone photoreceptors

  • Fill recorded cells with biocytin or fluorescent dyes

  • Use OPN1SW antibodies to confirm cone subtype identity after recording

• Optogenetic approaches:

  • Express optogenetic tools under OPN1SW promoter control

  • Verify expression patterns using OPN1SW antibodies

  • Manipulate S-cone activity and measure downstream effects

• Visual behavior assays:

  • Assess color discrimination abilities in animal models

  • Correlate behavioral performance with OPN1SW expression patterns

  • Evaluate the consequences of genetic or pharmaceutical interventions on both behavior and protein expression

• In vivo imaging with ex vivo validation:

  • Use adaptive optics to image cone mosaics in living subjects

  • After tissue collection, apply OPN1SW antibodies to identify cone subtypes

  • Create precise maps linking in vivo function to molecular identity

These integrated approaches bridge the gap between molecular mechanisms and visual function, providing comprehensive insights into how OPN1SW contributes to color vision under normal and pathological conditions.